As of Apr 28
| -0.44 / -0.27%|
The 19 analysts offering 12-month price forecasts for Amgen have a median target of 185.00, with a high estimate of 206.00 and a low estimate of 135.00. The median estimate represents a +15.22% increase from the last price of 160.56.
The current consensus among 25 polled investment analysts is to Buy stock in Amgen. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.